Grant: Master's Award: Canada Graduate Scholarships
McGill University
$17,500.00
Single cell sequencing technology: a tool to better understand genetic risk factors for Type-2 diabetes
FY 2021-22
Summary
Advances in genetics have increased our understanding of hereditary diseases and their pathologies. New sequencing technology has allowed for the study of different aspects of the human genome, providing researchers with a large range of tools to dissect the underpinnings of disease onset. Despite great successes in research and treatment of diseases governed by one or few genes, there are still many obstacles to overcome in the study of complex diseases such as Type-2 diabetes, which are influenced by many genes. Representing 90 percent of diabetes cases in Canada, and with nearly 500 new diagnoses every day, understanding the genetic causes behind Type-2 diabetes is crucial to finding an effective treatment for the disease. To address this challenge, researchers have developed approaches that can integrate different types of sequencing data to provide more detailed information on the genome. Although these approaches have enabled researchers to uncover novel mechanisms in disease onset, they do not integrate data at the resolution of individual cells (more commonly referred to as ;single cell data), which provides more pertinent information in tissues and diseases that are composed of many cell types, such as the pancreas for Type-2 diabetes. Existing methods also have limited accuracy in identifying specific gene regulatory elements of interest when building the gene networks involved in disease progression. In this project, we aim to expand upon past methods to incorporate single cell data and use more powerful computational methods to identify specific elements of interest that influence disease onset. Our work will provide a better representation of the complex gene networks that are perturbated in Type-2 diabetes, improving drug discovery and disease prevention.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
466752
Name
Osakwe Adrien
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Single cell sequencing technology: a tool to better understand genetic risk factors for Type-2 diabetes
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Bioinformatics; Gene Regulation; Genetic Risk Factors; Integrative Epigenetics; Single Cell Sequencing; Transcriptomics; Type 2 Diabetes
Abstract
Advances in genetics have increased our understanding of hereditary diseases and their pathologies. New sequencing technology has allowed for the study of different aspects of the human genome, providing researchers with a large range of tools to dissect the underpinnings of disease onset. Despite great successes in research and treatment of diseases governed by one or few genes, there are still many obstacles to overcome in the study of complex diseases such as Type-2 diabetes, which are influenced by many genes. Representing 90 percent of diabetes cases in Canada, and with nearly 500 new diagnoses every day, understanding the genetic causes behind Type-2 diabetes is crucial to finding an effective treatment for the disease. To address this challenge, researchers have developed approaches that can integrate different types of sequencing data to provide more detailed information on the genome. Although these approaches have enabled researchers to uncover novel mechanisms in disease onset, they do not integrate data at the resolution of individual cells (more commonly referred to as ;single cell data), which provides more pertinent information in tissues and diseases that are composed of many cell types, such as the pancreas for Type-2 diabetes. Existing methods also have limited accuracy in identifying specific gene regulatory elements of interest when building the gene networks involved in disease progression. In this project, we aim to expand upon past methods to incorporate single cell data and use more powerful computational methods to identify specific elements of interest that influence disease onset. Our work will provide a better representation of the complex gene networks that are perturbated in Type-2 diabetes, improving drug discovery and disease prevention.
Competitiondate
202112
Approvedterm2
1 yr 0 mth
Pinamesdelim
Osakwe, Adrien
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~